Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05375617 · ClinicalTrials.gov registry record
European Prospective Investigation Into Childhood Cancer
A clinical trial of Acute Lymphoblastic Leukemia and Brain Tumor, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,400
- Enrollment target
- 1
- Study location
NCT05375617 is a study of Acute Lymphoblastic Leukemia and Brain Tumor that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,400 participants, above the 371-participant average among 131 other Acute Lymphoblastic Leukemia trials with a reported enrollment target (277% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05375617, a study of Acute Lymphoblastic Leukemia and Brain Tumor, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,400 participants
- Enrollment target
- 1
- Study location
Study Summary
Over the last decades, research has shown that poor nutritional status can adversely impact prognosis and increase toxicities during treatment for childhood cancer. EPICkids is a collaboration between the International Initiative for Pediatrics and Nutrition, the International Agency for Research on Cancer, and sites throughout three Southern European countries (Spain, Greece, and Italy). The primary aim of EPICkids is to establish an informational resource on critical nutrition parameters wherein we can describe the trajectory of nutritional status among Southern European children and adolescents with acute lymphoblastic leukemia (ALL) and favorable biology brain tumors, investigate lifestyle behaviors, sociodemographic factors, and quality of life and correlate these indicators with clinical outcomes. The specimens obtained with the proposed study will foster future studies on nutrition and prevalent childhood cancer as well as establish a framework to develop evidence-based guidelines for European children with cancer, utilizing regional, European data. We plan to recruit 900 patients with ALL and 1400 patients with a favorable biology brain tumor over five years. Nutrition parameters and lifestyle factors will be measured at systematic timepoints over the study period. Stool and blood specimens will be collected at each timepoint. Eligible patients will be between 3 and 21 years of age.
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2023-07-07 |
| Est. Completion | 2031-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05375617
The ClinicalTrials.gov registry entry for NCT05375617 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 371-participant average among 131 other Acute Lymphoblastic Leukemia trials with a reported enrollment target (277% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Lymphoblastic Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT05375617 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05375617 about?
NCT05375617 is a clinical study titled "European Prospective Investigation Into Childhood Cancer". Over the last decades, research has shown that poor nutritional status can adversely impact prognosis and increase toxicities during treatment for childhood cancer. EPICkids is a collaboration between the International Initiative for Pediatrics and Nutrition, the International Agency for Research on...
What is the current status of trial NCT05375617?
This trial is currently recruiting. The enrollment target is 1,400 participants. The study started on 2023-07-07. Estimated completion is 2031-03-01.
What conditions does trial NCT05375617 study?
This clinical trial studies the following conditions: Acute Lymphoblastic Leukemia, Brain Tumor.
What interventions are being tested in trial NCT05375617?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT05375617?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05375617 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Lymphoblastic Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
RECRUITING
-
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RECRUITING · Phase 1
-
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
RECRUITING · Phase 1
-
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
RECRUITING · Phase 1
-
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RECRUITING · Phase 1
-
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.